Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
about
Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockadeImportant modifications by sugammadex, a modified γ-cyclodextrin, of ion currents in differentiated NSC-34 neuronal cellsUse of neuromuscular blockers and neostigmine for general anesthesia and its association with neuraxial blockade: A retrospective studyA miracle that accelerates operating room functionality: sugammadex.Sugammadex: A revolutionary drug in neuromuscular pharmacologyA disease-drug-phenotype matrix inferred by walking on a functional domain network.Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex.Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients.Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function.The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade.Effects of Sugammadex and Neostigmine on Renal Biomarkers.Sugammadex.Effect of Smoking on Reversing Neuromuscular Block.Sugammadex in anesthesia practice.Sugammadex: a novel approach to reversal of neuromuscular blockade.The pharmacology of airway management in critical care.Sugammadex: clinical development and practical use.Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.Intraoperative hemodynamics with vecuronium bromide and rocuronium for maintenance under general anesthesia.Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.New and developing anesthesia drugs.Efficacy of different doses of sugammadex after continuous infusion of rocuroniumAnesthesia for ambulatory surgery.Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study.Comparison of reversal and adverse effects of sugammadex and combination of - Anticholinergic-Anticholinesterase agents in pediatric patients.Update on the management of neuromuscular block: focus on sugammadex.Comparison of effects of sugammadex and neostigmine on QTc prolongation in rabbits under general anesthesia.Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.Effect of paralytic type on time to post-intubation sedative use in the emergency department.A case of atrioventricular block (Wenckebach type) induced by sugammadex.[Update on muscle relaxation : What comes after succinylcholine, rocuronium and sugammadex?]Recent advances in neuromuscular block during anesthesia.Effect of sugammadex on rocuronium induced changes in pancreatic mast cells.
P2860
Q24240695-444DED2B-B8E0-43C7-8412-657BA9563C36Q30366011-EC743DA0-7705-410F-BBA4-5C787CE0D698Q33879788-29697A52-958C-4763-AC0F-8B71715F2954Q34114015-5E9B9128-C9EB-40C2-B40C-EF2904A68CD6Q34236933-7D57C91B-B07F-4724-AC3B-8C111BE7A2D5Q34331097-66308361-EED1-4988-AD8C-40B22D3C8B32Q34613962-FEAEA473-615F-4CCB-8C19-FCE09110ABB1Q34711497-44044016-30BD-4C5B-AAC7-B6E58B2A5FD5Q35601463-F951DB81-B3FD-4693-9ACB-2AF9F2E11D73Q35774826-56A53D57-F96C-4ACF-93F0-1843EE22356EQ36169726-D3CD5D47-FA97-4D71-940A-F68F9AD5E072Q36322683-5E24122B-C865-4951-B751-452920DF3592Q36339866-F5FAB8F6-6DEB-418B-9237-A214C9D04266Q36684999-7FA57D47-109B-4EAE-B78E-29184AAA9315Q37167705-ECB05B04-C33B-49D1-B553-A4F3850C9F53Q37249871-683A338C-BAE1-47C6-BB23-972D56EB4AA7Q37803242-879E09F2-C2D7-4D45-A922-5564746C7AE0Q37838422-3B95553F-F4A9-4171-B2CD-7021F4F0BAA7Q37857544-28A598F8-EA83-41AD-B0C8-C9328F3C8084Q38178677-C4FED50B-BE46-4C8D-98A9-932E692E3958Q38625776-067AC03F-AB77-441F-8370-BB5B91A6841CQ38628482-73D99D37-BCAC-4829-B84C-2B49C6DE02E7Q38707992-8662E950-D6D9-4CD5-89AD-3A4F81FED352Q39076634-DA92BD3E-5B50-4DF5-8430-460FB8442E74Q39433314-FD7346B1-A166-4E53-B054-641005FA8F89Q41312449-1B0FE379-4881-4A06-A9D1-71460D330CF2Q42200748-9EC5DF05-FD98-4EDF-8BDB-FF3F10D299D4Q42913787-316C98FF-EA49-4DE7-A95A-519CBAC4A55FQ43010324-FE4FF657-0D0D-49BD-BE86-7A76E374AFC3Q43162064-3612C234-A5AE-41D1-BE2B-FD478C8D88F1Q47773137-6E797CCF-673E-4628-9FC9-1D04B68692EFQ47991326-7E3D66C4-E099-4408-B477-6F9B17344EE3Q48116896-17D6AD05-060F-4E24-991C-321BB06892B0Q48168206-51F06BDC-90B0-4007-81E9-A8E3600770DFQ50803411-DC2BD827-4CDF-4C05-84B7-2EA165781198Q51745476-4F0B3BC4-34BD-41A8-9544-115672B94876Q53113373-D2C2D0CE-626F-4894-A9F8-78EB9546A260
P2860
Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@ast
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@en
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@nl
type
label
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@ast
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@en
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@nl
prefLabel
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@ast
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@en
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@nl
P2093
P1476
Sugammadex reversal of rocuron ...... late and edrophonium-atropine.
@en
P2093
Burcu Tufanogullari
Kevin Klein
Ozlem Sacan
Paul F White
P304
P356
10.1213/01.ANE.0000248224.42707.48
P407
P577
2007-03-01T00:00:00Z